GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Icon (ICLR) Future 3-5Y EPS without NRI Growth Rate : 13.14 (As of Jul. 23, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Icon Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Icon's Future 3-5Y EPS without NRI Growth Rate is 13.14.

Competitive Comparison of Icon's Future 3-5Y EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Icon's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Icon's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Icon's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Icon's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Icon  (NAS:ICLR) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Icon Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Icon's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Icon Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
RVTY QGEN EXAS MEDP ILMN CRL GH RDNT SHC DGX TSE:2397 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA
Traded in Other Exchanges
IJF:Germany
Address
South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Website
https://www.iconplc.com
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.